The Centre for Bioengineering and Biotechnology is a catalyst for advancing bioengineering and biotechnology research and innovation through industry collaborations and partnerships.
More than 150 faculty members, from every faculty on campus, are actively engaged with the centre, working in collaboration to provide a resource of varying expertise.
Our mandate is to build healthy, active partnerships between centre researchers and corporate members through collaborative projects, mutual interest building, and networking events.
To learn more about partnerships, please email us.
Vision:
The Centre for Bioengineering & Biotechnology (CBB) enables interdisciplinary research across the university to address global challenges in human health and help translate those research results rapidly into practice, policy and impactful health outcomes. Achieving this vision will help the University of Waterloo to cement an international reputation at the interface of technology and human health.
Mission:
To achieve this vision, CBB's mission is to:
- Enable knowledge translation and support of the interdisciplinary research community through seminars, networking opportunities, and support of student groups
- Be a conduit to Waterloo's ecosystem of unique health related R&D and clinical resources
- Cultivate relationships with key stakeholders in technology, human, animal and environmental health and practice including industry, hospitals, community, and international bodies
- Provide Project Coordination/Management for large/inter-institutional projects
Join us:
To become a member of CBB, you can start by filling out a quick survey. We will then be in touch to discuss further.
News
CBB member Shirley Tang named one of Canada’s 100 Most Powerful Women
Shirley Tang, a CBB member and professor in the Department of Chemistry, has been named among the top 100 most powerful women in Canada for her research impact and empowering women in STEM by the Women’s Executive Network (WXN).
Dr. Vivek Goel, leading public-health researcher, named as next president and vice‑chancellor of the University of Waterloo
Dr. Vivek Goel is recognized in Canada and around the world as a leading public-health researcher, health-services evaluation expert, and champion for the use of research evidence in health policy making.
He also currently serves on the boards of the Vector Institute, TRIUMF, the Canadian Institute for Health Information, Canada Health Labs, and the Post Promise.
New laser imaging project led by CBB member Parsin Haji Reza could precisely guide doctors during brain surgery
Researchers have taken an important step in the development of a microscope to precisely guide doctors during surgery to remove brain tumors
For the first time, a team led by engineers at the University of Waterloo used laser imaging technology to almost instantly identify cancerous tissue with accuracy comparable to laboratory tests that take up to two weeks.
That means the Photoacoustic Remote Sensing (PARS) imaging system could tell doctors where a tumor ends and healthy tissue begins so they know exactly where to cut.